Andrew Rhoades on Muck Rack

Andrew Rhoades

Verified
(He/Him)
Philadelphia
As seen in: Healio Primary Care, Flipboard, EIN News, Endocrine Today, Healio, Healio Gastroenterology, Healio Neurology, Healio Women’s Health & OB/GYN, HemOnc Today, Nephrology News & Issues, Primary Care Optometry News and
Writer at @GoHealio | Formerly @igglesnews, @National_Digest, @PhilliesNation, @Sjuhawknews | Saint Joseph’s University 2020 | Opinions are my own
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Andrew

Contact Andrew, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Food preservatives raise risk for CVD, high blood pressure

|
By Andrew Rhoades 
| Healio Primary Care
Key takeaways: Higher intake of antioxidant and non-antioxidant preservatives raised the risk for CVD and hypertension. The data provide further support favoring minimally or non-processed foods, a researcher said. Several frequently used food preservatives may increase the risk for CVD and hypertension, according to findings published in European Heart Journal.
Open in Who Shared Issue with article?

Smartwatch app accurately detects seizures in people with epilepsy Original

|
By Andrew Rhoades 
| Healio Neurology
EpiWatch demonstrated a sensitivity of 98% and a daily false alarm rate of 0.08. The app may help to reduce the risk for sudden death and other complications tied to tonic-clonic seizures. A smartwatch app accurately identified tonic-clonic seizures and seizures with major convulsions in people with epilepsy, according to data published in Neurology Open Access.
Open in Who Shared View Duplicates (2) Issue with article?

FDA approves Zaynich for complicated UTIs

|
By Andrew Rhoades 
| Healio Primary Care
FDA approves Zaynich for complicated UTIs Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: Zaynich had a higher treatment response rate vs. meropenem in trials and was generally well tolerated.
Open in Who Shared Issue with article?
See all 1,581 articles

Actions

Share this page

Get in touch with Andrew

Contact Andrew, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified